Skip to content
Gold Mining News – Lifestyle
Home
Sample Page
Author:
NORTHWEST BIOTHERAPEUTICS, INC.
Northwest Biotherapeutics Presents Updated Survival Data from Phase III Trial of DCVax®-L For Glioblastoma Using Individual Patient Level Data in Multiple Independent Analyses
July 8, 2026
Northwest Biotherapeutics Announces Scientific Presentation on Propensity Score Matching at the British Neuro-Oncology Society Annual Meeting
July 2, 2026
Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform
April 30, 2026
Northwest Biotherapeutics Announces Establishment Of the Company’s Own Dedicated Leukapheresis Clinic
April 21, 2026